Pancreatic Cancer Europe is a European multi-stakeholder platform which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer.

News

PCE Early Career Investigator (ECI) Short-term Scientific Stay Award (S3A) – 2022

  THE ORGANISATION  The Pancreatic Cancer Europe (PCE) is a European multi-stakeholder platform, which aims at bringing together experts from all over Europe including academics, physicians, politicians, patient groups, journalists and industry with a common interest and willingness to improve care for patients with pancreatic cancer.  THE AWARD  PCE launches a call for a short-term…   …Read More »PCE Early Career Investigator (ECI) Short-term Scientific Stay Award (S3A) – 2022

Membership campaign 2021

Spring is arriving and it brings along the PCE Membership campaign. As discussed during the PCE Annual General Meeting on the 26th of November 2020, the membership campaign we intend to launch today aims at increasing the membership, reactivating old members and involving them pro-actively in PCE initiatives. The first step of the campaign is…   …Read More »Membership campaign 2021

Workshops for members during April 2021

PCE is offering to its members a series of workshops during April 2021, with the intention to know better the members’ activities, to know how we can support them in their activities and to explore how they can be engaged in PCE activities. The workshops are scheduled as follows: – 8 April 2021: introductory workshop…   …Read More »Workshops for members during April 2021

Impact of COVID-19 pandemic on pancreatic cancer

PCE is supporting a survey to investigate the current and expected impact of COVID-19 pandemic on pancreatic cancer research and care worldwide. The survey has been launched by a group of 30 young researchers from UK, Italy, and the Netherlands, belonging to the University of Glasgow (UK), the University of Verona (IT), the Italian Pancreatic…   …Read More »Impact of COVID-19 pandemic on pancreatic cancer

PancreOS Pancreatic Cancer Overall Survival Registry

European Parliament Event Hosted by MEP Joanna Kopcińska Wednesday, 18 November 2020 14:00 – 15:00 – Online Only CLICK HERE TO REGISTER

Pancreatic Cancer Heatmap now online!

Following several months of development, we are happy to unveil the PCE heatmap. Conceived as a powerful tool to compare the pancreatic cancer patients’ situation in each European country, the heatmap provides information on awareness situation, national policy, diagnosis, research… We are always looking for more data and information to enrich the heatmap. Should you want to add some data for your country, please contact directly the Secretariat.

Visit the PCE heatmap ›

Did you know that Pancreatic Cancer has the lowest survival rate of all cancers?

pancreatic cancer europe

Help us to reverse the Trend!

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20203.

Launched in July 2014 a call for action on pancreatic cancer by Members of the European Parliament has been the key driver for the activities of the platform. Since its launch, Pancreatic Cancer Europe has been developping the Pancreatic Cancer Declaration, in order to ensure real change in European policies for pancreatic cancer patients.

Pancreatic cancer is currently the 4th leading cause of death by cancer in Europe. If no action is taken, it is set to be 2nd by 20203.

Patients affected with pancreatic cancer lose 98% of their healthy life expectancy at the point of diagnosis5.

Today, a diagnosis of pancreatic cancer is generally associated with a death sentence and few patients are alive one year after diagnosis, while an earlier diagnosis could help reduce the mortality of the disease. If diagnosed in time, chances of survival increase.

  1. Farthing, M, Roberts, S, Samuel D, Williams D, et al. Survey of digestive health across Europe: Final report. Part 1: The burden of gastrointestinal diseases and the organisation and delivery of gastroenterology services across Europe, United European Gastroenterology Journal, December 2014 vol. 2 no. 6 539-543
  2. Malvezzi M, Bertuccio P, Levi F, La Vecchia C, Negri E, et al. European cancer mortality predictions for the year 2013. Annals of Oncol. 2013; 24:792-800
  3. Pancreatic Cancer Action Network. The alarming rise of pancreatic cancer deaths in The United States: Why we need to stem the tide today, 2012. www.pancan.org/wp-content/uploads/2013/01/incidence_report_2012_executive_summary.pdf [Last accessed April 2014]
  4. Carrato et al, 2015. “A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs.” DOI 10.1007/s12029-015-9724-1
  5. Carrato A, Falcone A, Ducreux, M, Valle, J, Parnaby A, Djazouli K, Alnwick-Allu K, Hutchings A, Palaska C, Parthenaki I. A systematic review of the burden of pancreatic cancer in Europe: Real-world impact on survival, quality-of-life, and costs. J Gastrointest Cancer 2015 Sep;46(3):201-11